1. Home
  2. PEGA vs RGEN Comparison

PEGA vs RGEN Comparison

Compare PEGA & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pegasystems Inc.

PEGA

Pegasystems Inc.

HOLD

Current Price

$44.53

Market Cap

9.9B

Sector

Technology

ML Signal

HOLD

Logo Repligen Corporation

RGEN

Repligen Corporation

HOLD

Current Price

$135.23

Market Cap

8.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PEGA
RGEN
Founded
1983
1981
Country
Employees
N/A
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
9.9B
8.1B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
PEGA
RGEN
Price
$44.53
$135.23
Analyst Decision
Buy
Buy
Analyst Count
13
11
Target Price
$63.42
$177.18
AVG Volume (30 Days)
2.9M
733.6K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
0.27%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$15.42
$17.86
Revenue Next Year
$11.56
$12.44
P/E Ratio
$20.86
$5,321.47
Revenue Growth
N/A
N/A
52 Week Low
$29.84
$102.97
52 Week High
$68.10
$175.77

Technical Indicators

Market Signals
Indicator
PEGA
RGEN
Relative Strength Index (RSI) 45.29 30.21
Support Level $35.89 $130.40
Resistance Level $43.27 $146.36
Average True Range (ATR) 2.79 7.59
MACD 0.51 -1.63
Stochastic Oscillator 57.76 14.70

Price Performance

Historical Comparison
PEGA
RGEN

About PEGA Pegasystems Inc.

Founded in 1983, Pegasystems provides a suite of solutions for customer engagement and business process management. The company's key offering is the Pega Infinity platform, which combines business process management with customer relationship management applications. The company focuses on enterprise-size customers in the financial, insurance, and healthcare industries.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: